Showing 1 - 8 results of 8 for search 'Daheng He (9189701)', query time: 0.01s Refine Results
  1. 1
    Numerical values of data in Figs 1–6 and S1–S6 Figs.

    Numerical values of data in Figs 1–6 and S1–S6 Figs. by Fengyi Mao (15073242)

    Published 2025
    Other Authors:
    Save to List
    Saved in:
  2. 2
    BTB domain and CNC homolog 1 (BACH1) is stabilized by Polo-like kinase 1 (PLK1).

    BTB domain and CNC homolog 1 (BACH1) is stabilized by Polo-like kinase 1 (PLK1). by Fengyi Mao (15073242)

    Published 2025
    Other Authors:
    Save to List
    Saved in:
  3. 3
    Knockdown of BTB domain and CNC homolog 1 (BACH1) impedes Polo-like kinase 1 (PLK1)-induced phenotype in melanoma.

    Knockdown of BTB domain and CNC homolog 1 (BACH1) impedes Polo-like kinase 1 (PLK1)-induced phenotype in melanoma. by Fengyi Mao (15073242)

    Published 2025
    Other Authors:
    Save to List
    Saved in:
  4. 4
    Overexpressed Polo-like kinase 1 (PLK1) promotes metastasis and metabolic reprogramming in melanoma.

    Overexpressed Polo-like kinase 1 (PLK1) promotes metastasis and metabolic reprogramming in melanoma. by Fengyi Mao (15073242)

    Published 2025
    Other Authors:
    Save to List
    Saved in:
  5. 5
    List of transcription factors associated with the top-regulated genes.

    List of transcription factors associated with the top-regulated genes. by Fengyi Mao (15073242)

    Published 2025
    Other Authors:
    Save to List
    Saved in:
  6. 6
    Polo-like kinase 1 (PLK1) is involved in melanoma progression.

    Polo-like kinase 1 (PLK1) is involved in melanoma progression. by Fengyi Mao (15073242)

    Published 2025
    Other Authors:
    Save to List
    Saved in:
  7. 7
    Inhibition of Polo-like kinase 1 (PLK1) synergizes with Vemurafenib in the treatment of melanoma.

    Inhibition of Polo-like kinase 1 (PLK1) synergizes with Vemurafenib in the treatment of melanoma. by Fengyi Mao (15073242)

    Published 2025
    Other Authors:
    Save to List
    Saved in:
  8. 8
    Polo-like kinase 1 (PLK1) induces Vemurafenib resistance in melanoma.

    Polo-like kinase 1 (PLK1) induces Vemurafenib resistance in melanoma. by Fengyi Mao (15073242)

    Published 2025
    Other Authors:
    Save to List
    Saved in:

Search Tools: